Skip to main content
Clinical Trials/NCT03440853
NCT03440853
Completed
N/A

Technology Assisted Stepped Collaborative Care Intervention (TASCCI) to Improve Patient-centered Outcomes in Hemodialysis Patients

University of Pittsburgh1 site in 1 country160 target enrollmentMarch 28, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
End-Stage Renal Disease
Sponsor
University of Pittsburgh
Enrollment
160
Locations
1
Primary Endpoint
Change in pain from baseline to 12 weeks
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This study evaluates a collaborative care intervention in reducing depression, fatigue and pain symptoms and improving health related quality of life in hemodialysis patients. Half of participants will receive the collaborative care intervention, while the other half will receive technology delivered health education information.

Detailed Description

End-stage renal disease patients on hemodialysis experience substantial symptom burden with fatigue, pain and depression among the most debilitating and existing as symptom clusters. These symptom clusters can exacerbate one another, and are independent and strong predictors of poor health-related quality of life in hemodialysis patients. This study will look at the effect of a 12 week stepped care intervention on changes in depression, pain or fatigue and health related quality of life.

Registry
clinicaltrials.gov
Start Date
March 28, 2018
End Date
June 30, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Manisha Jhamb

Associate Professor of Medicine

University of Pittsburgh

Eligibility Criteria

Inclusion Criteria

  • 18 years or older
  • undergoing thrice-weekly maintenance hemodialysis for \> 3 months
  • English speaking
  • able to provide informed consent
  • no evidence of thought disorder, delusions or active suicidal ideation

Exclusion Criteria

  • thought disorder, delusions or active suicidal ideation
  • active substance abuse
  • too ill or cognitively impaired to participate based on clinicians' judgment
  • anticipated life expectancy of less than 1 year
  • unable or unwilling to adhere to study protocol
  • participating in another clinical trial or taking an investigational drug
  • scheduled for living donor kidney transplant within next 6 months
  • relocating to another dialysis unit within 6 months

Outcomes

Primary Outcomes

Change in pain from baseline to 12 weeks

Time Frame: Baseline and Post 12 week intervention

Pain symptoms will be measured using the Brief Pain Inventory

Change in fatigue from baseline to 12 weeks

Time Frame: Baseline and Post 12 week intervention

Fatigue symptoms will be measured using the FACIT-F

Change in depression from baseline to 12 weeks

Time Frame: Baseline and Post 12 week intervention

Depressive symptoms will be measured using the Beck Depression Inventory-II

Secondary Outcomes

  • Change in adherence to hemodialysis treatments(Baseline and Post 12 week intervention)
  • Change in adherence to medications(Baseline, 3 month, 6 month, 12 month)
  • Change in adherence to fluid restriction(Baseline, 3 month, 6 month, 12 month)

Study Sites (1)

Loading locations...

Similar Trials